MedPath

Shanghai Jiaotong Medical University Attached Ruijin Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia

Recruiting
Conditions
Acute Myeloid Leukemia
Interventions
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Drug: Chemotherapy
First Posted Date
2024-06-13
Last Posted Date
2024-11-07
Lead Sponsor
Ruijin Hospital
Target Recruit Count
50
Registration Number
NCT06458257
Locations
🇨🇳

Ruijin Hospital Affiliated to Shanghai Jiaotong University School Of Medicine, Shanghai, Shanghai, China

The Efficacy of Allo-HSCT in ND HR-CBF-AML

Recruiting
Conditions
Acute Myeloid Leukemia
Interventions
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Drug: Chemotherapy
First Posted Date
2024-06-13
Last Posted Date
2024-11-07
Lead Sponsor
Ruijin Hospital
Target Recruit Count
90
Registration Number
NCT06458244
Locations
🇨🇳

Ruijin Hospital Affiliated to Shanghai Jiaotong University School Of Medicine, Shanghai, Shanghai, China

CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT

Not Applicable
Recruiting
Conditions
Hematologic Malignancy
Interventions
First Posted Date
2024-06-10
Last Posted Date
2025-01-09
Lead Sponsor
Ruijin Hospital
Target Recruit Count
250
Registration Number
NCT06449586
Locations
🇨🇳

Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Wuhan, Hubei, China

🇨🇳

Ruijin Hospital of Shanghai Jiaotong University, Shanghai, Shanghai, China

🇨🇳

The First Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

and more 2 locations

Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

First Posted Date
2024-06-04
Last Posted Date
2024-06-04
Lead Sponsor
Ruijin Hospital
Target Recruit Count
152
Registration Number
NCT06441097

Blinatumomab Maintenance After Allo-HSCT

Phase 2
Not yet recruiting
Conditions
High Risk Acute Lymphoblastic Leukemia
Interventions
First Posted Date
2024-06-03
Last Posted Date
2024-06-03
Lead Sponsor
Ruijin Hospital
Target Recruit Count
59
Registration Number
NCT06438796

Effect of Oxycodone on Anxiety State in Painless Abortion

Early Phase 1
Not yet recruiting
Conditions
Abortion Complication
Interventions
First Posted Date
2024-05-30
Last Posted Date
2024-05-30
Lead Sponsor
Ruijin Hospital
Target Recruit Count
300
Registration Number
NCT06435949

Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients

Phase 2
Recruiting
Conditions
Breast Cancer
Interventions
Radiation: Boost irradiation
First Posted Date
2024-05-08
Last Posted Date
2024-05-08
Lead Sponsor
Ruijin Hospital
Target Recruit Count
24
Registration Number
NCT06404697
Locations
🇨🇳

Ruijin hospital, Shanghai jiaotong university school of medicine, Shanghai, Shanghai, China

Analysis of Deep Brain Nuclei LFP and Cortical EEG Signals During the Recovery From General Anesthesia

Recruiting
Conditions
Deep Brain Stimulation Surgery
Consciousness, Loss of
Electrophysiology
General Anesthesia
First Posted Date
2024-05-06
Last Posted Date
2024-05-13
Lead Sponsor
Ruijin Hospital
Target Recruit Count
42
Registration Number
NCT06400901
Locations
🇨🇳

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

a Ultrasonographic Measurement of Intra-abdominal Pressure

Not yet recruiting
Conditions
Critical Care
First Posted Date
2024-04-30
Last Posted Date
2024-04-30
Lead Sponsor
Ruijin Hospital
Target Recruit Count
9
Registration Number
NCT06390605
Locations
🇨🇳

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer

Phase 2
Not yet recruiting
Conditions
Colon Cancer
Interventions
First Posted Date
2024-04-16
Last Posted Date
2024-04-16
Lead Sponsor
Ruijin Hospital
Target Recruit Count
56
Registration Number
NCT06368141
Locations
🇨🇳

Ruijin Hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath